miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

Drug resistance remains the major clinical barrier to successful treatment in epithelial ovarian carcinoma (EOC) patients, and the evidence of microRNA involvement in drug resistance has been recently emerging. Endothelin-1 (ET-1)/ET(A) receptor (ET(A)R) axis is aberrantly activated in chemoresistan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Sestito, Rosanna, Cianfrocca, Roberta, Rosanò, Laura, Tocci, Piera, Semprucci, Elisa, Di Castro, Valeriana, Caprara, Valentina, Ferrandina, Gabriella, Sacconi, Andrea, Blandino, Giovanni, Bagnato, Anna
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826186/
https://ncbi.nlm.nih.gov/pubmed/26675258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6546
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares